Skip to main content
US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
AL

ALBBYStock

Healthcare · HK

$7.70 last close 2026-11-06
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment ALBBY's does — no target price to set, unlike a price alert.

Sharia status
COMPLIANT
Per our in-house ratio engine
4 of 7 pass our own screen — the standards disagree
Purification 1.33% *HTR non-permissible income 1.35%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
🟢 STRONG BUY SETUP
Strong confluence across multiple layers — outperforming the market by 12.2%, RSI in healthy zone, Wall Street...
Scores: 4 bullish / 0 bearish
36
of 100
Setup confidence — system conviction, not win probabilityD

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure2 of 3 timeframes bullish · 23.1% aligned
VolumeRelative volume 0.0× the 20-day average
Momentum10-day rate of change +4.7%
Overall readSTRONG BUY SETUP

ALBBY is currently considered halal (Sharia-compliant), per our in-house ratio engine. See the full ratio breakdown and business-activity screen below for the reasoning.

This sits among 436 compliant Healthcare stocks we track. See compliant Healthcare stocks →

Market & analysts
Wall Street consensus
BUY
18 analysts
Institutional own.
0.0%
of shares
Momentum (10d)
+4.7%
rate of change
SMC grade
D · 36
23.1% aligned
1.33% *
Purification ratio (secondary provider, uncertain)
1.35%
Non-permissible income — HTR, from filings (2026-03-31)
D · 36
SMC grade — 23.1% timeframe alignment
+4.7%
Rate of change (10d)
BUY
Wall Street consensus (18)
0.0%
Institutional ownership

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-03-31. These ratios come from the issuer's own published statements rather than structured SEC data.

Business activity: not screened

We have not screened this company's line of business, so these ratios say nothing about whether what it does is permissible.

AAOIFI Pass 3 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt 0.11% 30.00% Pass
Interest-bearing investments 19.32% 30.00% Pass
Non-permissible income 1.35% 5.00% Pass
Usmani Fail 3 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 0.52% 33.00% Pass
Interest-bearing investments 44.02% 33.00% Fail
Non-liquid assets 50.64% at least 20.00% Pass
Non-permissible income 1.35% 5.00% Pass
MSCI Fail 2 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 0.26% 33.33% Pass
Cash + interest-bearing securities 44.02% 33.33% Fail
Accounts receivable 49.36% 33.33% Fail
Non-permissible income 1.35% 5.00% Pass
FTSE Fail 3 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 0.26% 33.33% Pass
Cash + interest-bearing securities 44.02% 33.33% Fail
Accounts receivable 49.36% 50.00% Pass
Non-permissible income 1.35% 5.00% Pass
Dow Jones Islamic Market Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 0.08% 33.00% Pass
Cash + interest-bearing securities 13.32% 33.00% Pass
Accounts receivable 1.62% 33.00% Pass
Non-permissible income 1.35% 5.00% Pass
S&P Shariah Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 0.09% 33.00% Pass
Cash + interest-bearing securities 14.79% 49.00% Pass
Accounts receivable 1.79% 49.00% Pass
Non-permissible income 1.35% 5.00% Pass
MSCI M-Series Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 0.09% 33.33% Pass
Cash + interest-bearing securities 14.79% 33.33% Pass
Accounts receivable 16.59% 49.00% Pass
Non-permissible income 1.35% 5.00% Pass

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

FTSE Shariah Global Equity Index Series (% of total assets)receivables ratio 0.6pts
AAOIFI Standard 21 (% of market cap)non permissible income ratio 3.6pts
Usmani (% of total assets)non permissible income ratio 3.6pts
MSCI Islamic Index (% of total assets)receivables ratio 16.0pts
Usmani (% of total assets)investments ratio 11.0pts
MSCI Islamic Index (% of total assets)cash and interest ratio 10.7pts

The numbers the ratios are built from

Read from ALBBY's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $5.0B 2026-03-31 yahoo:annualTotalRevenue
Interest-bearing debtShort and long-term borrowings $8.7M 2026-03-31 yahoo:annualTotalDebt
Cash and interest-bearing securitiesCash, equivalents and marketable securities $1.5B 2026-03-31 yahoo:annualCashCashEquivalentsAndShortTermInvestments
Total assetsBalance sheet total $3.3B 2026-03-31 yahoo:annualTotalAssets
Market capDenominator for AAOIFI $7.6B live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $169.8B 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $183.8B 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $67.2M 2026-03-31 yahoo:annualInterestIncome

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

What changed, and when

Verdict history for ALBBY. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-09-07 No change recorded No verdict change for ALBBY has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.

Tracked since 2026-09-07.

16.3913.9611.549.116.692025-11-102026-05-122026-11-06

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
6.96
S2
7.30
S1
7.48
PIVOT
7.82
R1
8.00
R2
8.34
R3
8.52

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
7.47 – 8.09
±4.0% from 7.78, made 2026-09-27 · resolves 2026-10-04
STRONG SELL
from 19 indicators
61.9% of our last 5789 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 49.9% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG BUY
19 indicators
OscillatorsSTRONG BUY
3 buy · 3 neutral · 1 sell
Moving averagesSTRONG BUY
8 buy · 0 neutral · 4 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)55.20NEUTRAL
Stochastic %K (14)65.29NEUTRAL
CCI (20)121.18SELL
Williams %R (14)-34.71NEUTRAL
MACD (12,26,9)0.08BUY
ROC (10)13.57BUY
Momentum (10)0.92BUY
EMA (10)7.48BUY
SMA (10)7.36BUY
EMA (20)7.42BUY
SMA (20)7.36BUY
EMA (30)7.45BUY
SMA (30)7.37BUY
EMA (50)7.59BUY
SMA (50)7.50BUY
EMA (100)8.18SELL
SMA (100)7.90SELL
EMA (200)9.93SELL
SMA (200)9.98SELL

About ALBBY

Healthcare · Pharmaceutical Retailers

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in the People's Republic of China. It offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and various other health-related products. The company also provides medical and healthcare services, including medical checkups, testing, medical consultation, appointment-booking, physical examination, consultation, registration, vaccine, dentistry, psychology, optometry, and nursing services, as well as traditional chinese medicines. In addition, it engages in the digital tracking business; asset management; and operation of internet hospitals, as well as provision of network hospital, research, and Internet information services. Further, the company operates Alibaba Health, flagship platform of Alibaba Group for integrated online and offline medical and healthcare resources, providing one-stop healthcare solutions. It provides products and services to business-to-customer and business-to-business customers through offline pharmacy outlets, as well as online stores, such as Tmall, Taobao, Alipay, Taobao Instant Commerce, AMap, DingTalk, Freshippo, and Quark. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.

alihealth.cn ↗

Background via Yahoo Finance — informational, not part of the verdict.

Verdict

🟢 STRONG BUY SETUP

Strong confluence across multiple layers — outperforming the market by 12.2%, RSI in healthy zone, Wall Street broadly bullish. High conviction entry. Use `!plan ALBBY [entry] [stop] [target]` to size the position properly.

Scores: 4 bullish / 0 bearish

Grade verdict

Weak — low conviction, small size or skip

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily RANGING 27
⏱ 15-Min BULLISH 19
⏲ 5-Min BULLISH 59

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

+4.7%
Rate of change (10d)
0.0×
Volume vs its 20-day average

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-03 · Asset managers net 928584 (+5135)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.